메뉴 건너뛰기
Annals of Internal Medicine
Volumn 162, Issue 12, 2015, Pages 866-867
The lake wobegon effect: Why most patients are at below-Average risk
Author keywords

[No Author keywords available]
Indexed keywords

CANCER RISK; CARDIOVASCULAR RISK; HUMAN; NOTE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; CARDIOVASCULAR DISEASES; FEMALE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; STATISTICAL MODEL; UNITED STATES; VERY ELDERLY;
EID: 84932153315     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-2767     Document Type: Note
Times cited : (15)
References (7)
  • 1
    • 34548575455 scopus 로고    scopus 로고
    • Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification
    • Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298:1209-12.
    • (2007) JAMA , vol.298 , pp. 1209-1212
    • Kent, D.M.1    Hayward, R.A.2
  • 2
    • 84868314511 scopus 로고    scopus 로고
    • When the average applies to no one: Personalized decision making about potential benefits of lung cancer screening
    • Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med. 2012;157:571-3. doi: 10.7326/0003-4819-157-8-201210160-00524
    • (2012) Ann Intern Med , vol.157 , pp. 571-573
    • Bach, P.B.1    Gould, M.K.2
  • 3
    • 0037159557 scopus 로고    scopus 로고
    • An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase
    • Kent DM, Hayward RA, Griffith JL, Vijan S, Beshansky JR, Califf RM, et al. An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase. Am J Med. 2002;113:104-11.
    • (2002) Am J Med , vol.113 , pp. 104-111
    • Kent, D.M.1    Hayward, R.A.2    Griffith, J.L.3    Vijan, S.4    Beshansky, J.R.5    Califf, R.M.6
  • 4
    • 0036460157 scopus 로고    scopus 로고
    • Is primary angioplasty for some as good as primary angioplasty for all?
    • Kent DM, Schmid CH, Lau J, Selker HP. Is primary angioplasty for some as good as primary angioplasty for all? J Gen Intern Med. 2002;17:887-94.
    • (2002) J Gen Intern Med , vol.17 , pp. 887-894
    • Kent, D.M.1    Schmid, C.H.2    Lau, J.3    Selker, H.P.4
  • 5
    • 25444528059 scopus 로고    scopus 로고
    • Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty
    • Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI)-2 Investigators
    • Thune JJ, Hoefsten DE, Lindholm MG, Mortensen LS, Andersen HR, Nielsen TT, et al; Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI)-2 Investigators. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation. 2005;112:2017-21.
    • (2005) Circulation , vol.112 , pp. 2017-2021
    • Thune, J.J.1    Hoefsten, D.E.2    Lindholm, M.G.3    Mortensen, L.S.4    Andersen, H.R.5    Nielsen, T.T.6
  • 6
    • 77956811462 scopus 로고    scopus 로고
    • Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
    • Vickers AJ, Cronin AM, Björk T, Manjer J, Nilsson PM, Dahlin A, et al. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. BMJ. 2010;341: c4521. doi:10.1136/bmj.c4521
    • (2011) BMJ , vol.341 , pp. c4521
    • Vickers, A.J.1    Cronin, A.M.2    Björk, T.3    Manjer, J.4    Nilsson, P.M.5    Dahlin, A.6
  • 7
    • 84897492117 scopus 로고    scopus 로고
    • Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: Population based cohort study
    • Carlsson S, Assel M, Sjoberg D, Ulmert D, Hugosson J, Lilja H, et al. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study. BMJ. 2014;348:g2296. doi:10.1136/bmj.g2296
    • (2014) BMJ , vol.348 , pp. g2296
    • Carlsson, S.1    Assel, M.2    Sjoberg, D.3    Ulmert, D.4    Hugosson, J.5    Lilja, H.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.